<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01909960</url>
  </required_header>
  <id_info>
    <org_study_id>PHRCIR11-DR-BALEDENT</org_study_id>
    <secondary_id>2011-A01633-38</secondary_id>
    <nct_id>NCT01909960</nct_id>
  </id_info>
  <brief_title>Flow MRI in Normal Pressure Hydrocephalus</brief_title>
  <acronym>HydroFlux</acronym>
  <official_title>Benefit of Flow Magnetic Resonance Imaging in the Management of Normal Pressure Hydrocephalus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Normal pressure hydrocephalus diagnosis based on quantitative study of cerebro-spinal fluid
      and blood flow by phase contrast magnetic resonance imaging.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cerebrospinal fluid (CSF) stroke volume evolution other 6 months</measure>
    <time_frame>Day 1 (baseline), Day 180</time_frame>
    <description>Measurement of cerebrospinal fluid (CSF) stroke volume via flow MRI at the Sylvius' aqueduct, pontine cistern and spinal spaces levels and determination of its evolution</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood flow analysis : evolution other 6 months</measure>
    <time_frame>Day 1 (baseline), Day 180</time_frame>
    <description>Assessment of arterial (internal carotids and cerebral arteries) and venous (sagittal sinus, straight sinus) blood flow in terms of mean cerebral blood outflow and stroke volume and determination of blood flow evolution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Larson's score evolution over 6 months</measure>
    <time_frame>Day 1, Day 180</time_frame>
    <description>Record symptoms on walking, living conditions and urinary disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological test evolution over 6 months</measure>
    <time_frame>Day1, Day 180</time_frame>
    <description>Consists in mini mental status evaluation (MMSE) for cognitive evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood flow analysis : evolution other one year</measure>
    <time_frame>Day 1 (baseline) and Day 365</time_frame>
    <description>Assessment of arterial (internal carotids and cerebral arteries) and venous (sagittal sinus, straight sinus) blood flow in terms of mean cerebral blood outflow and stroke volume and determination of blood flow evolution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Larson's score evolution over one year</measure>
    <time_frame>Day 1 and Day 365</time_frame>
    <description>Record symptoms on walking, living conditions and urinary disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological test evolution over one year</measure>
    <time_frame>Day1, Day 365</time_frame>
    <description>Consists in mini mental status evaluation (MMSE) for cognitive evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cerebrospinal fluid (CSF) stroke volume evolution other one year</measure>
    <time_frame>Day1 (baseline), Day 365</time_frame>
    <description>Measurement of cerebrospinal fluid (CSF) stroke volume via flow MRI at the Sylvius' aqueduct, pontine cistern and spinal spaces levels and determination of its evolution</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Normal Pressure Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who will undergo flow imaging and neurosurgery (shunting). (25% of the studied population)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical follow-up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who will undergo flow imaging but not surgery (75% of the studied population)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flow imaging</intervention_name>
    <description>Quantitative flow study was performed by 2D phase-contrast velocity-encoded cine MRI (repetition/echo time, 15/7 ms; field of view = 140 x 140 mm²; matrix size = 256 x 128, flip angle = 25 degrees,one excitation, slice thickness = 5 mm). Cerebrospinal fluid and blood flows are measured with a velocity-encoding value of 5-10 cm/s and 80 cm/s respectively. Peripheral gating was used to cover the entire cardiac cycle with retrospective cardiac synchronization of 32 quantitative flow-encoded images per cycle.
Clinical examination consists in Larson's score and MMSE</description>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_label>Clinical follow-up</arm_group_label>
    <other_name>Flow MRI</other_name>
    <other_name>Cine phase-constrast magnetic resonance imaging</other_name>
    <other_name>CSF pulsatility</other_name>
    <other_name>Hydrodynamic</other_name>
    <other_name>Cerebral blood flow</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ventricular dilation seen on morphological magnetic resonance imaging (MRI)

          -  Walking disorder

          -  Cognitive disorder

          -  Participants gave their written informed consent

        Exclusion Criteria:

          -  Contra-indication to MRI

          -  Obstructive tumoral hydrocephalus

          -  Curatorship or tutorship

          -  Pregnancy or lactation

          -  No social assurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Balédent, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier Balédent, PhD</last_name>
    <phone>+33 3 22 66 86 73</phone>
    <email>olivier.baledent@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <state>Basse Normandie</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick Courtheoux, MD,PhD</last_name>
      <phone>+33 2 31 06 46 88</phone>
      <email>courtheoux-p@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick Courtheoux, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evelyne Emery, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <state>Haute Normandie</state>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel Gerardin, MD</last_name>
      <phone>+33 2 32 88 86 31</phone>
      <email>emmanuel.gerardin@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuel Gerardin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Proust, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lille</name>
      <address>
        <city>Lille</city>
        <state>Nord Pas de Calais</state>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Baroncini, MD</last_name>
      <phone>+33 3 20 44 65 55</phone>
      <email>marc.baroncini@inserm.fr</email>
    </contact>
    <investigator>
      <last_name>Marc Baroncini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Paul Lejeune, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre Pruvo, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Balédent, PhD</last_name>
      <phone>+33 3 22 66 86 73</phone>
      <email>olivier.baledent@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Daniel Le Gars, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Balédent, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Fichten, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine Gondry-Jouet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hervé Deramond, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2013</study_first_submitted>
  <study_first_submitted_qc>July 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2013</study_first_posted>
  <last_update_submitted>November 10, 2016</last_update_submitted>
  <last_update_submitted_qc>November 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Normal pressure hydrocephalus</keyword>
  <keyword>Flow MRI</keyword>
  <keyword>Dementia</keyword>
  <keyword>Cerebrospinal fluid</keyword>
  <keyword>Shunt</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
    <mesh_term>Hydrocephalus, Normal Pressure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

